Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq

BioSig Technologies (BSGM) has completed a share exchange with Streamex Exchange Corporation, forming a combined entity focused on tokenizing real-world assets, particularly commodities, with Streamex becoming a wholly-owned subsidiary of BioSig. Streamex's CEO Henry McPhie will lead the combined company as CEO, while Streamex's Chairman Morgan Lekstrom will become Chairman of the Board; strategic advisors Frank Giustra and Mathew August have also been added. Existing Streamex shareholders are entitled to receive 75% of the fully diluted BioSig common stock outstanding subject to shareholder approval, positioning the company to capitalize on the $142.851 trillion global commodity market.

Analysis

BioSig Technologies (BSGM) has executed a transformative share exchange with Streamex Exchange Corporation, pivoting its business model to focus on the tokenization of real-world assets (RWAs), specifically targeting the US$142.851 trillion global commodity market. This strategic shift involves Streamex becoming a wholly-owned subsidiary and its leadership, Henry McPhie and Morgan Lekstrom, assuming CEO and Chairman roles respectively in the combined entity, while former BioSig CEO Anthony Amato remains on the board. The transaction is bolstered by the addition of prominent strategic advisors, Frank Giustra, founder of major commodity and entertainment companies like Wheaton Precious Metals and GoldCorp, and Mathew August, an expert in US capital markets, signaling strong industry backing. While Streamex shareholders are set to receive 75% of the fully diluted BioSig common stock post-shareholder approval (initially receiving 19.9% pre-transaction due to Nasdaq rules), current BioSig shareholders will retain 25% ownership. This restructuring, characterized by a strongly positive sentiment (score 0.75) and high market impact (score 0.7), aims to leverage Streamex's expertise in RWA tokenization to unlock value in commodity finance, though it is contingent on BioSig shareholder approval and potentially a new Nasdaq listing application due to the change of control.

Key Decisions for Investors

• Recognize this transaction as a fundamental pivot for BioSig (BSGM) into the high-growth, albeit developing, RWA tokenization market for commodities, effectively creating a new investment profile for the company.
• Evaluate the significant dilution for existing BSGM shareholders, who will ultimately hold 25% of the combined entity post-approval, against the potential long-term value creation from Streamex's specialized business model, experienced new leadership, and high-profile strategic advisors like Frank Giustra.
• Monitor key upcoming catalysts, including the BioSig shareholder vote on the full share issuance, progress on any required Nasdaq listing application, and initial announcements regarding commodity tokenization projects or partnerships, as these will be critical indicators of the combined entity's early trajectory.